Fertility-Sparing Treatment for Early-Stage Cervical, Ovarian, and Endometrial Malignancies.

ABSTRACT: Approximately 20% of gynecologic malignancies are diagnosed in reproductive-aged women, and standard-of-care surgical treatment often precludes future fertility. In early-stage disease, shared decision making about fertility-sparing medical and surgical approaches may give well-selected patients the opportunity to pursue their family-building goals without compromising long-term survival. Although future fertility is an important consideration for young women with cancer, rates of fertility-sparing procedures remain low. Moreover, because data on pregnancy rates and outcomes after fertility-sparing treatments are limited, it is challenging to counsel patients on realistic expectations. This review examines the critical oncologic outcomes of fertility-sparing approaches in early-stage gynec

SUBMITTER: Nitecki R 

PROVIDER: S-EPMC7680432 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature